Hyperfine, Inc. (HYPR)
0.5449
-0.02
(-2.97%)
USD |
NASDAQ |
Nov 18, 16:00
0.5308
-0.01
(-2.59%)
After-Hours: 20:00
Hyperfine Enterprise Value : 33.30M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 33.30M |
| November 17, 2026 | 35.08M |
| November 16, 2026 | 40.23M |
| November 13, 2026 | 42.27M |
| November 12, 2026 | 47.58M |
| November 11, 2026 | 50.98M |
| November 10, 2026 | 47.78M |
| November 09, 2026 | 50.50M |
| November 06, 2026 | 51.85M |
| November 05, 2026 | 48.23M |
| November 04, 2026 | 55.12M |
| November 03, 2026 | 48.97M |
| November 02, 2026 | 52.40M |
| October 30, 2026 | 51.65M |
| October 29, 2026 | 54.41M |
| October 28, 2026 | 58.76M |
| October 27, 2026 | 55.05M |
| October 26, 2026 | 52.24M |
| October 23, 2026 | 52.37M |
| October 22, 2026 | 52.52M |
| October 21, 2026 | 54.69M |
| October 20, 2026 | 57.64M |
| October 19, 2026 | 57.98M |
| October 16, 2026 | 55.60M |
| October 15, 2026 | 58.28M |
| Date | Value |
|---|---|
| October 14, 2026 | 60.41M |
| October 13, 2026 | 65.87M |
| October 12, 2026 | 71.70M |
| October 09, 2026 | 74.28M |
| October 08, 2026 | 75.27M |
| October 07, 2026 | 65.60M |
| October 06, 2026 | 67.83M |
| October 05, 2026 | 69.20M |
| October 02, 2026 | 70.36M |
| October 01, 2026 | 68.01M |
| September 30, 2026 | 61.25M |
| September 29, 2026 | 54.01M |
| September 28, 2026 | 57.29M |
| September 25, 2026 | 54.89M |
| September 24, 2026 | 53.05M |
| September 23, 2026 | 52.42M |
| September 22, 2026 | 54.02M |
| September 21, 2026 | 51.48M |
| September 18, 2026 | 51.86M |
| September 17, 2026 | 50.60M |
| September 16, 2026 | 50.75M |
| September 15, 2026 | 53.61M |
| September 14, 2026 | 53.91M |
| September 11, 2026 | 52.43M |
| September 10, 2026 | 52.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Glaukos Corp. | 13.56B |
| Abbott Laboratories | 208.41B |
| AngioDynamics, Inc. | 457.01M |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.733B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.981M |
| Revenue (Quarterly) | 5.96M |
| Total Expenses (Quarterly) | 11.94M |
| EPS Diluted (Quarterly) | -0.0564 |
| Gross Profit Margin (Quarterly) | 56.74% |
| Profit Margin (Quarterly) | -100.4% |
| Earnings Yield | -55.18% |
| Normalized Earnings Yield | -57.94 |